New Risk Score for Lung Cancer Outcomes
Author Information
Author(s): Kössler Wolfgang, Fiebeler Anette, Willms Arnulf, ElAidi Tina, Klosterhalfen Bernd, Klinge Uwe
Primary Institution: Institute of Computer Science, Humboldt University, Berlin, Germany
Hypothesis
Can a new risk score based on correlation coefficients improve outcome prediction in NSCLC patients compared to traditional Cox regression models?
Conclusion
Combining protein expression analysis of CD68 and GAS6 with TNM staging improves prediction of outcomes in NSCLC patients.
Supporting Evidence
- High tumour stage (TNM) was predictive for poor survival.
- CD68 and Gas6 protein expression correlated with a favourable outcome.
- Cox regression model analysis predicted outcome more accurately than using each variable in isolation.
- The integrated score for individual risk (ISIR) identified 82% of patients as having a clear risk status.
Takeaway
Doctors can better predict how lung cancer will progress by looking at certain proteins and tumor stages together, rather than just one at a time.
Methodology
The study analyzed clinical data and protein expression in 63 NSCLC patients, using correlation coefficients to create a new risk score (ISIR) and comparing it to Cox regression models.
Potential Biases
Potential biases may arise from the selection of variables and the retrospective nature of the study.
Limitations
The study was conducted on a small cohort, and the findings need validation in larger studies.
Participant Demographics
The study included 63 patients with NSCLC, with no significant gender differences noted.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website